FBXO34 抗体 (AA 287-336)
Quick Overview for FBXO34 抗体 (AA 287-336) (ABIN6744113)
抗原
See all FBXO34 抗体适用
宿主
克隆类型
标记
应用范围
-
-
抗原表位
- AA 287-336
-
特异性
- Human FBXO34
-
预测反应
- Percent identity by BLAST analysis: Human, Mouse, Rat (100%) Bovine, Rabbit (92%) Horse, Guinea pig (85%).
-
纯化方法
- Immunoaffinity purified
-
免疫原
-
Synthetic peptide located between aa287-336 of human FBXO34 (Q9NWN3, NP_060413). Percent identity by BLAST analysis: Human, Chimpanzee, Gorilla, Monkey, Mouse, Rat (100%), Hamster, Elephant, Bovine, Rabbit (92%), Marmoset, Horse, Guinea pig (85%).
Type of Immunogen: Synthetic peptide
-
-
anti-F-Box Protein 34 (FBXO34) (AA 1-711) antibody
FBXO34 适用: 人 WB, IF 宿主: 小鼠 Polyclonal unconjugated
anti-F-Box Protein 34 (FBXO34) (AA 600-629), (C-Term) antibodyFBXO34 适用: 人, Hamster WB, FACS, IHC (p) 宿主: 兔 Polyclonal RB23410 unconjugated
anti-F-Box Protein 34 (FBXO34) (AA 1-100) antibodyFBXO34 适用: 人 WB, ELISA 宿主: 小鼠 Polyclonal unconjugated
anti-F-Box Protein 34 (FBXO34) (AA 71-120) antibodyFBXO34 适用: 人, 大鼠, 豚鼠, 小鼠, Cow, 兔, 猴 WB 宿主: 兔 Polyclonal unconjugated
anti-F-Box Protein 34 (FBXO34) (N-Term) antibodyFBXO34 适用: 人, 大鼠 WB 宿主: 兔 Polyclonal unconjugated
anti-F-Box Protein 34 (FBXO34) (N-Term) antibodyFBXO34 适用: 人, 大鼠, 豚鼠, 小鼠, Cow, 兔, 犬 WB 宿主: 兔 Polyclonal unconjugated
anti-F-Box Protein 34 (FBXO34) (Middle Region) antibodyFBXO34 适用: 人, 大鼠, 豚鼠, 小鼠, Cow, 兔, 犬, 马 WB 宿主: 兔 Polyclonal unconjugated
-
-
应用备注
-
Approved: WB (0.2 - 1 μg/mL)
Usage: Western Blot: Suggested dilution at 1 μg/mL in 5 % skim milk / PBS buffer, and HRP conjugated anti-Rabbit IgG should be diluted in 1: 50,000 - 100,000 as secondary antibody. -
说明
-
Target Species of Antibody: Human
-
限制
- 仅限研究用
-
-
-
状态
- Lyophilized
-
溶解方式
- Distilled water
-
浓度
- Lot specific
-
缓冲液
- Lyophilized from PBS with 2 % sucrose
-
注意事项
- Avoid repeat freeze-thaw cycles.
-
储存条件
- 4 °C,-20 °C
-
储存方法
-
Long term: -20°C, the use of 50% glycerol is recommended if storing aliquots in -20°C for long term use (up to 1 year)
Short term (less than 1 week): 4°C. Avoid freeze-thaw cycles.
-
-
-
